CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
Sun-Gi Kim, Byung-Kwon Kim, Kyumin Kim, Sungsoon Fang
Endocrinol Metab. 2016;31(4):500-504.   Published online December 20, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.4.500

Excel Download

Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
Endocrinology and Metabolism. 2016;31(4):500   Crossref logo
Link1 Link2 Link3

Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target
Journal of Lipids. 2012;2012:1-8   Crossref logo
Link1 Link2 Link3

Implications for Farnesoid X Receptor Signaling on Bile Acid Metabolism as a Potential Therapeutic Strategy for Nonalcoholic Fatty Liver Disease
The Korean Journal of Obesity. 2016;25(4):167-175   Crossref logo
Link1 Link2

Bile Acid Receptor Farnesoid X Receptor: A Novel Therapeutic Target for Metabolic Diseases
Journal of Lipid and Atherosclerosis. 2017;6(1):1   Crossref logo
Link1 Link2 Link3

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
Clinical and Translational Gastroenterology. 2018;9(6):e164   Crossref logo
Link1 Link2 Link3 Link4

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
Diabetes mellitus. 2018;20(6):449-453   Crossref logo
Link1 Link2

Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease
Digestive Diseases. 2015;33(3):426-432   Crossref logo
Link1 Link2

Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
Biomedicine & Pharmacotherapy. 2020;121:109609   Crossref logo
Link1 Link2

The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?
Hepatology. 2004;40(1):260-263   Crossref logo
Link1 Link2

Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-κB: New insights into hepatic inflammation
Hepatology. 2008;48(5):1383-1386   Crossref logo
Link1 Link2